Gerald T. Keusch MD

Professor, Infectious Diseases

Faculty, National Emerging Infectious Disease Lab

620 Albany St | (617) 358-9186
Gerald Keusch
Sections

Infectious Diseases

Biography

Dr. Keusch is a Professor of Medicine and International Health at Boston University Schools of Medicine and Public Health. He is an Associate Director of the National Emerging Infectious Diseases Laboratory Institute at BU and Director of the Collaborative Core.

Other Positions

Education

MD, Harvard Medical School, 1963

AB, Columbia College, 1958

Publications

Published on 9/17/2021

Keusch GT, Lam SK, Mackenzie JS, Saif L, Turner M. An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply. Lancet. 2021 Sep 17. PMID: 34543607.

Published on 7/31/2021

Lurie N, Keusch GT, Dzau VJ. Should global financing be the main priority for pandemic preparedness? - Authors' reply. Lancet. 2021 07 31; 398(10298):388-389. PMID: 34332679.

Published on 7/5/2021

Calisher CH, Carroll D, Colwell R, Corley RB, Daszak P, Drosten C, Enjuanes L, Farrar J, Field H, Golding J, Gorbalenya AE, Haagmans B, Hughes JM, Keusch GT, Lam SK, Lubroth J, Mackenzie JS, Madoff L, Mazet JK, Perlman SM, Poon L, Saif L, Subbarao K, Turner M. Science, not speculation, is essential to determine how SARS-CoV-2 reached humans. Lancet. 2021 07 17; 398(10296):209-211. PMID: 34237296.

Published on 3/9/2021

Lurie N, Keusch GT, Dzau VJ. Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development. Lancet. 2021 03 27; 397(10280):1229-1236. PMID: 33711296.

Published on 1/21/2021

Daszak P, Keusch GT, Phelan AL, Johnson CK, Osterholm MT. Infectious Disease Threats: A Rebound To Resilience. Health Aff (Millwood). 2021 02; 40(2):204-211. PMID: 33476187.

Published on 9/1/2020

Morens DM, Breman JG, Calisher CH, Doherty PC, Hahn BH, Keusch GT, Kramer LD, LeDuc JW, Monath TP, Taubenberger JK. The Origin of COVID-19 and Why It Matters. Am J Trop Med Hyg. 2020 Sep; 103(3):955-959. PMID: 32700664.

Published on 2/19/2020

Calisher C, Carroll D, Colwell R, Corley RB, Daszak P, Drosten C, Enjuanes L, Farrar J, Field H, Golding J, Gorbalenya A, Haagmans B, Hughes JM, Karesh WB, Keusch GT, Lam SK, Lubroth J, Mackenzie JS, Madoff L, Mazet J, Palese P, Perlman S, Poon L, Roizman B, Saif L, Subbarao K, Turner M. Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19. Lancet. 2020 03 07; 395(10226):e42-e43. PMID: 32087122.

Published on 8/31/2018

Ellenberg SS, Keusch GT, Babiker AG, Edwards KM, Lewis RJ, Lundgren JD, Wells CD, Wabwire-Mangen F, McAdam KPWJ. Reply to Jacob and Colebunders. Clin Infect Dis. 2018 08 31; 67(6):985-986. PMID: 29590323.

Published on 5/17/2018

London AJ, Omotade OO, Mello MM, Keusch GT. Ethics of randomized trials in a public health emergency. PLoS Negl Trop Dis. 2018 05; 12(5):e0006313. PMID: 29771907.

Published on 4/17/2018

Ellenberg SS, Keusch GT, Babiker AG, Edwards KM, Lewis RJ, Lundgren JD, Wells CD, Wabwire-Mangen F, McAdam KPWJ. Rigorous Clinical Trial Design in Public Health Emergencies Is Essential. Clin Infect Dis. 2018 04 17; 66(9):1467-1469. PMID: 29177461.

View full list of 392 publications.